XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells

Published:2013-10 Issue:10 Volume:37 Page:1350-1358
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Silva Karina Lani,de Souza Paloma Silva,Nestal de Moraes Gabriela,Moellmann-Coelho Arthur,Vasconcelos Flavia da Cunha,Maia Raquel Ciuvalschi

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)

FAPERJ/PPSUS

Instituto Nacional de Ciência e Tecnologia (INCT-para controle do câncer)

Programa de Oncobiologia (UFRJ/Fundação do Câncer)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference46 articles.

1. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med,2003

2. Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia;Cortes;J Clin Oncol,2011

3. Monitoring response and resistance to treatment in chronic myeloid leukemia;Assouline;Curr Oncol,2011

4. The interface between BCR-ABL-dependent and – independent: resistance signaling pathways in chronic myeloid leukemia;Nestal de Moraes;Leuk Res Treatment,2012

5. Targeting IAP proteins for therapeutic intervention in cancer;Fulda;Nat Rev Drug Discov,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling;Scientific Reports;2023-04-05

2. Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling;2023-01-03

3. Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line;Leukemia Research;2021-10

4. The Oncogenic Protein, Breakpoint Cluster (BCR)-Abelson Kinase (ABL) and Chronic Myelocytic Leukemia (CML): Insight Into the Drug Resistance Mechanisms and Approaches for Targeting BCR-ABL in CML;Reference Module in Biomedical Sciences;2021

5. Chaperonin-Containing TCP-1 Promotes Cancer Chemoresistance and Metastasis through the AKT-GSK3β-β-Catenin and XIAP-Survivin Pathways;Cancers;2020-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3